BactiQuant A/S (CPH:BACTIQ)
Denmark · Delayed Price · Currency is DKK 2.340
-0.040 (-1.68%)
Jul 28, 2026, 4:54 PM CET
BactiQuant Balance Sheet
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17.87 | 0.85 | 11.82 | 3.62 | 10.44 |
Cash & Short-Term Investments | 17.87 | 0.85 | 11.82 | 3.62 | 10.44 |
Cash Growth | 1993.60% | -92.78% | 226.74% | -65.34% | 1462.08% |
Accounts Receivable | 0.92 | 3.25 | 2.17 | 6.52 | 1.88 |
Other Receivables | 0.79 | 0.15 | 0.4 | 1.42 | 0.41 |
Total Trade Receivables | 1.71 | 3.41 | 2.57 | 7.94 | 2.29 |
Inventory | 3.96 | 4.34 | 3.72 | 3.41 | 3 |
Total Current Assets | 23.54 | 8.6 | 18.11 | 14.96 | 15.73 |
Net Property, Plant & Equipment | 0.87 | 1.9 | 2.39 | 3.3 | 4.17 |
Other Intangible Assets | 3.63 | 4.69 | 5.75 | 6.16 | 6.3 |
Long-Term Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Other Long-Term Assets | 0.46 | 0.45 | 0.44 | 0.4 | 0.39 |
Total Assets | 28.07 | 14.7 | 25.5 | 23.18 | 24.52 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.8 | 1.57 | 2.14 | 2.31 | 1.67 |
Accrued Expenses | - | 1.15 | 0.98 | 2.04 | 1.35 |
Short-Term Debt | 1.5 | 2.3 | 0 | - | - |
Current Portion of Leases | 0.19 | - | - | - | - |
Unearned Revenue | 0.37 | 1.17 | 0.18 | 0.69 | 0.44 |
Other Current Liabilities | 0.05 | - | - | - | - |
Total Current Liabilities | 3.91 | 5.52 | 2.65 | 4.16 | 2.41 |
Long-Term Debt | 6.41 | 7.82 | 7.79 | 3.84 | - |
Long-Term Leases | 0.12 | - | - | - | - |
Other Long-Term Liabilities | 0.36 | - | - | - | - |
Total Long-Term Liabilities | 6.9 | 8.49 | 8.44 | 4.71 | 1.04 |
Total Liabilities | 10.81 | 14.01 | 11.09 | 8.87 | 3.46 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.88 | 1.17 | 1.17 | 0.98 | 0.92 |
Accumulated Other Comprehensive Income | 0.43 | - | - | - | - |
Retained Earnings | 14.96 | -0.49 | 13.24 | 13.33 | 20.14 |
Shareholders' Equity | 17.26 | 0.69 | 14.41 | 14.31 | 21.06 |
Total Liabilities & Equity | 28.07 | 14.7 | 25.5 | 23.18 | 24.52 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.22 | 10.12 | 7.79 | 3.84 | 0 |
Net Cash (Debt) | 9.64 | -9.26 | 4.04 | -0.22 | 10.44 |
Net Cash Growth | - | - | - | - | 1462.08% |
Net Cash Per Share | 0.32 | -0.39 | 0.20 | -0.01 | 0.58 |
Book Value | 17.26 | 0.69 | 14.41 | 14.31 | 21.06 |
Book Value Per Share | 0.58 | 0.03 | 0.70 | 0.77 | 1.17 |
Tangible Book Value | 13.63 | -4 | 8.66 | 8.15 | 14.76 |
Tangible Book Value Per Share | 0.46 | -0.17 | 0.42 | 0.44 | 0.82 |